Application of Physiologically Based Pharmacokinetic (PBPK) Modeling Within a Bayesian Framework to Identify Poor Metabolizers of Efavirenz (PM), Using a Test Dose of Efavirenz

פריטים דומים

• Applications of linking PBPK and PD models to predict the impact of genotypic variability, formulation differences, differences in target binding capacity and target site drug concentrations on drug responses and variability
  מאת: Chetty, Manoranjenni, et al.
  יצא לאור: (2014)
• Prediction of the Pharmacokinetics, Pharmacodynamics, and Efficacy of a Monoclonal Antibody, Using a Physiologically Based Pharmacokinetic FcRn Model
  מאת: Chetty, Manoranjenni, et al.
  יצא לאור: (2015)
• Are Physiologically Based Pharmacokinetic Models Reporting the Right C(max)? Central Venous Versus Peripheral Sampling Site
  מאת: Musther, Helen, et al.
  יצא לאור: (2015)
• Changes in Individual Drug-Independent System Parameters during Virtual Paediatric Pharmacokinetic Trials: Introducing Time-Varying Physiology into a Paediatric PBPK Model
  מאת: Abduljalil, Khaled, et al.
  יצא לאור: (2014)
• Prediction of the pharmacokinetics, pharmacodynamics and efficacy of a monoclonal antibody, using a physiologically based pharmacokinetic FcRn model.
  מאת: Manoranjenni eChetty, et al.
  יצא לאור: (2015-01-01)